Bellicum Pharmaceuticals Stock Income Statements

Bellicum Pharmaceuticals Quarterly Income Statements Chart

Quarterly

Annual

Revenue

Gross Profit

Operating Profit

Net Income

Bellicum Pharmaceuticals Quarterly Income Statements Table

Quarterly

Annual

Unit: USD	2023-09-30	2023-03-31	2022-12-31	2022-09-30	2021-12-31	2021-09-30	2021-06-30	2020-12-31	2020-09-30	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31
revenue	1,000,000	8,000	500,000	1,000,000	500,000	5,000,000	700,000	500,000	0.004	5,133,000	103,000	1,391,000	516,000	312,000	292,000	362,000	154,000	-69,000	126,000	128,000	81,000	114,000	101,000	92,000	34,000	57,000	84,000	107,000	15,000	660,000	554,000	552,000	818,958
cost of revenue	0	0	0	0	0	0	0	500,000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
gross profit	1,000,000	8,000	500,000	1,000,000	500,000	5,000,000	700,000	0	0.004	5,133,000	103,000	1,391,000	516,000	312,000	292,000	362,000	154,000	-69,000	126,000	128,000	81,000	114,000	101,000	92,000	34,000	57,000	84,000	107,000	15,000	660,000	554,000	552,000	818,958
operating expenses
research and development	263,000	7,216,000	6,339,000	6,850,000	4,047,000	6,348,000	6,722,000	8,706,000	8,140,000	13,324,000	14,331,000	19,859,000	16,818,000	19,791,000	16,413,000	18,412,000	16,536,000	14,308,000	18,101,000	15,295,000	15,084,000	13,290,000	12,181,000	10,988,000	10,039,000	9,792,000	8,012,000	5,718,000	3,930,000	2,257,000	3,235,000	2,389,000	2,485,644
sales, general and administrative
total operating expenses	1,774,000	8,653,000	7,840,000	8,165,000	5,598,000	8,029,000	8,487,000	12,142,000	12,303,000	19,033,000	23,540,000	27,550,000	24,384,000	26,879,000	23,520,000	23,929,000	22,258,000	19,376,000	22,831,000	21,577,000	19,594,000	17,542,000	16,360,000	15,272,000	17,039,000	13,674,000	10,789,000	7,915,000	6,193,000	3,557,000	3,827,000	2,829,000	3,301,492
operating income	-1,000	-8,645,000	-7,340,000	-7,165,000	-5,098,000	-3,043,000	-7,787,000	-13,012,000	-12,303,000	-13,900,000	-23,437,000	-26,159,000	-23,868,000	-26,567,000	-23,228,000	-23,567,000	-22,104,000	-19,445,000	-22,705,000	-21,449,000	-19,513,000	-17,428,000	-16,259,000	-15,180,000	-17,005,000	-13,617,000	-10,705,000	-7,808,000	-49,390,000	-2,897,000	-3,273,000	-2,277,000	-2,482,534
net income	-763,000	-7,487,000	-6,195,002	-7,261,000	2,531,000	1,233,000	-2,202,000	18,783,000	-887,000	-28,981,000	-32,032,000	-26,936,000	-24,528,000	-27,220,000	-23,801,000	-24,175,000	-22,840,000	-21,918,000	-23,431,000	-21,973,000	-19,938,000	-17,719,000	-16,509,000	-15,075,000	-16,848,000	-13,408,000	-10,534,000	-7,758,000	-74,298,000	-4,096,000	-3,281,000	-2,290,000	-2,493,203

We provide you with 20 years income statements for Bellicum Pharmaceuticals stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Bellicum Pharmaceuticals stock. Explore the full financial landscape of Bellicum Pharmaceuticals stock with our expertly curated income statements.

The information provided in this report about Bellicum Pharmaceuticals stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.